Literature DB >> 23999029

Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.

Lidia Márquez1, Beatriz Camarena, Sandra Hernández, Cristina Lóyzaga, Luis Vargas, Humberto Nicolini.   

Abstract

Obsessive-compulsive disorder (OCD) is a psychiatric disorder whose etiology is not yet known. We investigate the role of three variants of the BDNF gene (rs6265, rs1519480 and rs7124442) by single SNP and haplotype analysis in OCD Mexican patients using a case-control and family-based association design. BDNF gene variants were genotyped in 283 control subjects, 232 OCD patients and first degree relatives of 111 OCD subjects. Single SNP analysis in case-control study showed an association between rs6265 and OCD with a high frequency of Val/Val genotype and Val allele (p=0.0001 and p=0.0001, respectively). Also, genotype and allele analysis of rs1519480 showed significant differences (p=0.0001, p=0.0001; respectively) between OCD and control groups. Haplotype analysis showed a high frequency of A-T (rs6265-rs1519480) in OCD patients compared with the control group (OR=2.06 [1.18-3.59], p=0.0093) and a low frequency of haplotype A-C in the OCD patients (OR=0.04 [0.01-0.16], p=0.000002). The family-based association study showed no significant differences in the transmission of any variant. Our study replicated the association between BDNF Val66Met gene polymorphism and OCD. Also, we found a significant association of rs1519480 in OCD patients compared with a control group, region that has never been analyzed in OCD. In conclusion, our findings suggest that BDNF gene could be related to the development of OCD.
© 2013 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Association study; BDNF; Haplotypes; OCD

Mesh:

Substances:

Year:  2013        PMID: 23999029     DOI: 10.1016/j.euroneuro.2013.08.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

Review 1.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

2.  Neuropsychiatric genetics in developing countries: Current challenges.

Authors:  Diego A Forero; Alberto Vélez-van-Meerbeke; Smita N Deshpande; Humberto Nicolini; George Perry
Journal:  World J Psychiatry       Date:  2014-12-22

Review 3.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

4.  The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Is Associated With Female Obsessive-Compulsive Disorder: An Updated Meta-Analysis of 2765 Obsessive-Compulsive Disorder Cases and 5558 Controls.

Authors:  Yanan Shang; Na Wang; En Zhang; Qian Liu; Hengfen Li; Xiaofeng Zhao
Journal:  Front Psychiatry       Date:  2022-01-12       Impact factor: 4.157

5.  No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.

Authors:  Hidehiro Umehara; Shusuke Numata; Makoto Kinoshita; Shinya Watanabe; Shutaro Nakaaki; Satsuki Sumitani; Tetsuro Ohmori
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-11       Impact factor: 2.570

6.  Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population.

Authors:  Mirna Edith Morales-Marín; Alma Delia Genis-Mendoza; Carlos Alfonso Tovilla-Zarate; Nuria Lanzagorta; Michael Escamilla; Humberto Nicolini
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-25       Impact factor: 2.570

7.  DNA Methylation at the Neonatal State and at the Time of Diagnosis: Preliminary Support for an Association with the Estrogen Receptor 1, Gamma-Aminobutyric Acid B Receptor 1, and Myelin Oligodendrocyte Glycoprotein in Female Adolescent Patients with OCD.

Authors:  Judith Becker Nissen; Christine Søholm Hansen; Anna Starnawska; Manuel Mattheisen; Anders Dupont Børglum; Henriette Nørmølle Buttenschøn; Mads Hollegaard
Journal:  Front Psychiatry       Date:  2016-03-18       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.